Elvax 40P implants: sustained, local release of bioactive molecules influencing mammary ductal development.
about
Mammary gland developmentKey stages in mammary gland development: the mammary end bud as a motile organ.Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness SusceptibilityNMDA antagonists in the superior colliculus prevent developmental plasticity but not visual transmission or map compressionThe development of the terminal end bud in the prepubertal-pubertal mouse mammary gland.Homeostatic plasticity studied using in vivo hippocampal activity-blockade: synaptic scaling, intrinsic plasticity and age-dependence.Lactation failure in Src knockout mice is due to impaired secretory activation.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary glandN-methyl-D-aspartate receptor antagonist desegregates eye-specific stripes.Accelerated mammary tumor onset in a HER2/Neu mouse model exposed to DDT metabolites locally delivered to the mammary gland.Activity-dependent regulation of substance P expression and topographic map maintenance by a cholinergic pathwayBidirectional modulation of visual plasticity by cholinergic receptor subtypes in the frog optic tectum.Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involutionIn vivo, cAMP stimulates growth and morphogenesis of mouse mammary ducts.Slow-release drug delivery through Elvax 40W to the rat retina: implications for the treatment of chronic conditions.Inhibitory plasticity facilitates recovery of stimulus velocity tuning in the superior colliculus after chronic NMDA receptor blockadeN-methyl-D-aspartate receptor antagonists disrupt the formation of a mammalian neural map.Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development.Diverse regulation of mammary epithelial growth and branching morphogenesis through noncanonical Wnt signalingDevelopment of rat female genital cortex and control of female puberty by sexual touchExpression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth.NMDA receptor blockade in the superior colliculus increases receptive field size without altering velocity and size tuning.Experimental down-regulation of the NMDA channel associated with synapse pruning.Tetrodotoxin prevents posttraumatic epileptogenesis in rats.Effects of postnatal blockade of cortical activity with tetrodotoxin upon the development and plasticity of vibrissa-related patterns in the somatosensory cortex of hamsters.Biomaterials and biotechnology: from the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering.Development and plasticity of local intracortical projections within the vibrissae representation of the rat primary somatosensory cortex.The Pursuit of Truth in the Company of Friends : In Memorium: Charles W. Daniel.
P2860
Q24629797-4972B428-0EF9-483E-BE27-748B25EAF710Q25257755-985E8D3B-CE27-423B-88E4-6B20E7B53DAFQ27309183-9E747735-04F9-425A-9D72-21DA034CCA0EQ28349306-9B8CC1FB-E5F4-4927-B749-A48E5A4B72AAQ32065826-DC25C3BF-B98C-4325-9448-2F652F93F846Q33293516-59B4AA06-2BC5-442E-8FC8-6938FDAFD30AQ33316234-5A7FE78E-9711-4486-A051-5D60D6CC6BB6Q33569159-5A301D8A-AA1C-48A8-B8A1-70205E0D5125Q34167993-2444C099-21E8-4D72-97D0-9476BB19E8D6Q34630674-C741281D-05F1-4706-8DB2-E5EB7D604CD0Q34633453-75250FFA-F131-46E3-BD2E-863EC0F4A432Q36229044-16AF3341-1578-49E3-AC5B-45124EF14D00Q36491012-40567348-6ECA-4C9D-95CB-A87D48026888Q36496664-968FB5B6-70A1-4B51-BE0C-D855D8BB8E90Q36531772-0F4C82D1-7E3F-4029-8811-712CC73D491FQ36586656-6CF719B7-8D98-495F-954F-7FF680649806Q36788228-C20DEF43-A297-4D60-A1B2-383E956256D6Q37083107-06D99C9B-03CF-42DA-A4F1-2789737081C8Q37288982-CAFD9B90-8696-433B-9496-D8A960CEB701Q37299801-4150574F-3C6D-4C72-94BF-60503649BBACQ38749136-C0E46512-CDF5-40D6-AFF9-7EAB150A5B07Q42089645-BDA2281E-A772-41A1-90D5-59D29D64A844Q43890949-2288EDE9-9A28-49FC-952E-5C1D6F1A679AQ44336726-B83375E1-EFD6-40C5-BA0C-B74DC165F15EQ46587039-0CCA8776-617B-4225-8856-0AA8006057FBQ48138876-F6C75BA3-CBD1-4BC4-9EBF-2D3C8780054AQ48227463-168B271C-4C28-4E86-90D5-AF24C03BBEF8Q48233888-5D845BEF-82B5-4C30-B1D0-602667E87D62Q48965715-593347F5-32E4-443C-8951-BC13172E1C76Q53791999-4CD4D742-8BF7-483C-9D6E-334C71E7248D
P2860
Elvax 40P implants: sustained, local release of bioactive molecules influencing mammary ductal development.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Elvax 40P implants: sustained, ...... ng mammary ductal development.
@ast
Elvax 40P implants: sustained, ...... ng mammary ductal development.
@en
type
label
Elvax 40P implants: sustained, ...... ng mammary ductal development.
@ast
Elvax 40P implants: sustained, ...... ng mammary ductal development.
@en
prefLabel
Elvax 40P implants: sustained, ...... ng mammary ductal development.
@ast
Elvax 40P implants: sustained, ...... ng mammary ductal development.
@en
P1476
Elvax 40P implants: sustained, ...... ng mammary ductal development.
@en
P2093
Silberstein GB
P304
P356
10.1016/0012-1606(82)90259-7
P407
P577
1982-09-01T00:00:00Z